Thilo Schroeder

Thilo Schroeder currently works at Circle Pharma, Inc., as Director from 2020, Revolution Medicines, Inc., as Independent Director from 2018, MOMA Therapeutics, Inc., as Director from 2020, Exo Therapeutics, Inc., as Director from 2021, and Nextech Invest AG, as Managing Partner from 2012.
Dr. Schroeder also formerly worked at Peloton Therapeutics, Inc., as Independent Director from 2014 to 2019, Blueprint Medicines Corp., as Independent Director in 2015, ImaginAb, Inc., as Director from 2016 to 2020, PMV Pharmaceuticals, Inc., as Independent Director from 2019 to 2022, Silverback Therapeutics, Inc., as Independent Director from 2020 to 2022, IDEAYA Biosciences, Inc., as Independent Director from 2018 to 2020, Black Diamond Therapeutics, Inc., as Director, Alterome Therapeutics, Inc., as Director, TRACON Pharmaceuticals, Inc., as Member-Observer Board, and Amgen Ltd., as Principal.
Dr. Schroeder received his undergraduate degree from Technische Universität Darmstadt, doctorate degree from the University of Zurich, and graduate degree in 2006 from Ecole Supérieure de Technologie des Biomolécules de Bordeaux.